紐澤西 的 移植物抗宿主病 臨床試驗
4 項針對 移植物抗宿主病 的研究正在 紐澤西 各地點尋找參與者。
紐澤西 的城市
官方研究文本（英文）
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年7月7日 · NCT07359859Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年7月7日 · NCT07216443A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年6月29日 · NCT07006506A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
- Memorial Sloan Kettering at Basking Ridge (Consent only), Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent only), Middletown
- Memorial Sloan Kettering Cancer Center @ Bergen (Consent only), Montvale
招募中2 期
4 歲及以上 · 所有性別 · 更新於 2026年5月22日 · NCT05675930資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。